Recombinant Human KIR2DL1/CD158a Fc Chimera Protein, CF
Description
Purity >95%, by SDS-PAGE with silver staining. MW (observed): 72-80 kDa, reducing conditions. MW (theoretical): 51 kDa (monomer). The Recombinant Human KIR2DL1/CD158a Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Human KIR2DL1/CD158a Fc Chimera Protein has been validated for the following applications: Bioactivity.
Size
50 ug
Concentration
n/a
Applications
Bioactivity
Other Names
CD158 antigen-like family member A, CD158a, CD158a antigen, CD158Ankat1, cl-42, killer cell immunoglobulin-like receptor 2DL1, killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1, killer Ig receptor, killer inhibitory receptor 2-2-1, KIR221, MHC class I NK cell receptor, Natural killer-associated transcript 1, NKAT, NKAT-1, NKAT1KIR-K64, p58 killer cell inhibitory receptor KIR-K64, p58 natural killer cell receptor clones CL-42/47.11, p58 NK cell inhibitory receptor NKR-K6,47.11, p58 NK receptor CL-42/47.11, p58.1, p58.1 MHC class-I-specific NK receptor